DE69227583D1 - Arylmorpholine, herstellung und verwendung - Google Patents

Arylmorpholine, herstellung und verwendung

Info

Publication number
DE69227583D1
DE69227583D1 DE69227583T DE69227583T DE69227583D1 DE 69227583 D1 DE69227583 D1 DE 69227583D1 DE 69227583 T DE69227583 T DE 69227583T DE 69227583 T DE69227583 T DE 69227583T DE 69227583 D1 DE69227583 D1 DE 69227583D1
Authority
DE
Germany
Prior art keywords
arylmorpholine
production
human
depression
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69227583T
Other languages
English (en)
Other versions
DE69227583T2 (de
Inventor
Nariman Mehta
Grady BOSWELL
James Kelley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE69227583D1 publication Critical patent/DE69227583D1/de
Application granted granted Critical
Publication of DE69227583T2 publication Critical patent/DE69227583T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DE69227583T 1991-04-23 1992-04-22 Arylmorpholine, herstellung und verwendung Expired - Fee Related DE69227583T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919108629A GB9108629D0 (en) 1991-04-23 1991-04-23 Heterocyclic pharmaceutical compounds,preparation and use
PCT/GB1992/000733 WO1992018489A1 (en) 1991-04-23 1992-04-22 Arylmorpholine, preparation and use

Publications (2)

Publication Number Publication Date
DE69227583D1 true DE69227583D1 (de) 1998-12-17
DE69227583T2 DE69227583T2 (de) 1999-04-01

Family

ID=10693740

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227583T Expired - Fee Related DE69227583T2 (de) 1991-04-23 1992-04-22 Arylmorpholine, herstellung und verwendung

Country Status (17)

Country Link
US (2) US5648347A (de)
EP (1) EP0583271B1 (de)
JP (1) JP3130040B2 (de)
AT (1) ATE173252T1 (de)
AU (1) AU668863B2 (de)
CA (1) CA2108967C (de)
DE (1) DE69227583T2 (de)
DK (1) DK0583271T3 (de)
ES (1) ES2124256T3 (de)
FI (1) FI934680A0 (de)
GB (1) GB9108629D0 (de)
HU (1) HU219458B (de)
IE (1) IE921260A1 (de)
NZ (1) NZ242421A (de)
PT (1) PT100415B (de)
WO (1) WO1992018489A1 (de)
ZA (1) ZA922910B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
US7098206B2 (en) 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
NZ529316A (en) 1998-01-21 2004-05-28 Glaxo Group Ltd Pharmaceutically active morpholinol
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
FR2796069B3 (fr) * 1999-07-09 2001-08-24 Sanofi Synthelabo Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes
US7323462B2 (en) 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
GB0228787D0 (en) * 2002-12-10 2003-01-15 Pfizer Ltd Morpholine dopamine agonists
CA2508262C (en) * 2002-12-10 2009-12-01 Pfizer Inc. Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
EP2571858B1 (de) * 2010-05-21 2018-06-20 Research Triangle Institute Phenylmorpholine und analoge davon
CA2800219C (en) 2010-05-21 2019-03-12 Research Triangle Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
CN105949142B (zh) * 2016-05-21 2018-03-27 南华大学 具有抗抑郁活性的单一手性化合物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997469A (en) * 1961-08-22 Preparation of substituted
GB851311A (en) * 1958-04-02 1960-10-12 Geigy Ag J R Morpholine compounds and their production
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
GB1336732A (en) * 1970-10-28 1973-11-07 Istituto Gentili Spa Pisa Diethanolamine derivatives
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
FR2517305B1 (fr) * 1981-12-01 1985-10-25 Lafon Labor Nouveaux derives de 2-phenyl-morpholine et leur utilisation en therapeutique
FR2553410B1 (fr) * 1983-10-14 1986-05-16 Lafon Labor Nouveaux derives de 2-tolyl-morpholine utiles en therapeutique
FR2553411B1 (fr) * 1983-10-14 1986-08-01 Lafon Labor Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8417170D0 (en) * 1984-07-05 1984-08-08 Wellcome Found Heterocyclic pharmaceutical compounds
US4803200A (en) * 1987-10-02 1989-02-07 A. H. Robins Company, Incorporated Substituted dialkanolamines, sulfur analogs and condensed 1,4-oxazine derivatives thereof in viral disease treatment
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use

Also Published As

Publication number Publication date
ZA922910B (en) 1994-01-24
US5648347A (en) 1997-07-15
DK0583271T3 (da) 1999-07-26
CA2108967A1 (en) 1992-10-24
FI934680A (fi) 1993-10-22
NZ242421A (en) 1994-10-26
HU9303000D0 (en) 1994-01-28
JP3130040B2 (ja) 2001-01-31
AU668863B2 (en) 1996-05-23
HU219458B (hu) 2001-04-28
ES2124256T3 (es) 1999-02-01
ATE173252T1 (de) 1998-11-15
JPH06506675A (ja) 1994-07-28
EP0583271B1 (de) 1998-11-11
CA2108967C (en) 2002-10-08
AU1575392A (en) 1992-11-17
EP0583271A1 (de) 1994-02-23
FI934680A0 (fi) 1993-10-22
WO1992018489A1 (en) 1992-10-29
PT100415A (pt) 1993-06-30
US5760224A (en) 1998-06-02
IE921260A1 (en) 1992-11-04
GB9108629D0 (en) 1991-06-12
PT100415B (pt) 1999-08-31
DE69227583T2 (de) 1999-04-01
HUT70531A (en) 1995-10-30

Similar Documents

Publication Publication Date Title
SE9604786D0 (sv) New compounds
SE9504661D0 (sv) New compounds
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ATE206611T1 (de) Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
MX9707453A (es) Derivados de quinazolina.
ES2141957T3 (es) Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
SE9802206D0 (sv) Novel compounds
HUP0300615A2 (hu) Sibutramint és orlistatot tartalmazó gyógyszerkészítmény
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
SE9504662D0 (sv) New compounds
ATE240101T1 (de) Verwendung von 2-phenyl-3- aroylbenzothiophenderivaten zur herstellung eines medikaments zur knochen- und bruchheilung
DK0802920T3 (da) Fusacandin-antisvampemidler
SE9603284D0 (sv) New compounds
DK0772438T3 (da) Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling
MX9701528A (es) Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee